✦ LIBER ✦

Ranibizumab vs. pegaptanib: a cost-effectiveness study?

✍ Scribed by Viroj Wiwanitkit

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to: Ranibizumab vs. pegaptanib:

✍ Luis Javier Hernández-Pastor 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 47 KB

Cost-effectiveness of ranibizumab compar

✍ Luis Javier Hernández-Pastor; Ana Ortega; Alfredo García-Layana; Joaquín Girálde 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 240 KB

PSS13 COST-EFFECTIVE ANALYSIS OF PEGAPTA

✍ LY Lu; W McGhan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Cost-Effectiveness Analysis of Ranibizum

✍ Kostas Athanasakis; Vasilios Fragoulakis; Vasiliki Tsiantou; Panagiotis Masaouti 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 551 KB

PMC21 COST-EFFECTIVENESS SENSITIVITY TO

✍ D Muston 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Cost-effectiveness modeling of dental im

✍ P. Bouchard; F. Renouard; D. Bourgeois; O. Fromentin; M.H. Jeanneret; A. Beresni 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB